NasdaqGS - Delayed Quote USD
CG Oncology, Inc. (CGON)
26.50
+0.32
+(1.22%)
At close: June 12 at 4:00:01 PM EDT
25.93
-0.57
(-2.15%)
After hours: June 12 at 6:24:48 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 29, 2024 | -- |
| DECHENG VENTURE CAPITAL LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 29, 2024 | -- |
| KASTURI VIJAY M.D. Officer | Purchase | Jan 29, 2024 | 1,315 |
| POST LEONARD E Director | Sale | May 21, 2025 | 0 |
| ROCHE CORLEEN M Chief Financial Officer | Purchase | Jan 29, 2024 | 2,000 |
| SONG HONG FANG Director | Sale | Dec 16, 2024 | -- |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
15.42
-2.10%
ELVN Enliven Therapeutics, Inc.
19.66
+0.28%
CNTA Centessa Pharmaceuticals plc
12.04
-3.60%
MLYS Mineralys Therapeutics, Inc.
14.92
-4.05%
NUVL Nuvalent, Inc.
77.91
+1.30%
PHVS Pharvaris N.V.
17.23
+1.06%
PCVX Vaxcyte, Inc.
34.46
-2.77%
AGIO Agios Pharmaceuticals, Inc.
34.50
+0.26%
JANX Janux Therapeutics, Inc.
25.56
+0.39%
DYN Dyne Therapeutics, Inc.
14.46
-0.75%